We have previously shown that p53 disruption sensitizes certain cancer cell types to cisplatin (CDDP) (Fan et al., 1995) . In the present study we investigated the role of the p53 downstream eector, p21
Introduction
DNA damage-induced G 1 arrest is associated with the p53-dependent induction of the WAF1/CIP1 gene that encodes a 21 kDa inhibitor of the cyclin-dependent kinases (Dulic et al., 1994; El-Diery et al., 1993 Harper et al., 1993 Harper et al., , 1995 . Evidence that Cip1/Waf1 was important for G 1 arrest came from studies in murine embryonic ®broblasts (MEF) from transgenic mice lacking p21 genes (Brugarolas et al., 1995; Deng et al., 1995) and a human colorectal cancer cell line disrupted for p21 function (Waldman et al., 1995) . p21 also binds to proliferating cell nuclear antigen (PCNA) (Li et al., 1994; Shivji et al., 1994; Waga et al., 1994) , indicating a potential role for p21 in DNA replication and/or DNA repair. p21 is not, however, required for p53-dependent apoptosis since thymocytes from transgenic mice lacking p21 genes still undergo apoptosis following irradiation (Deng et al., 1995) .
The recent generation of cells lacking p21 genes provides the opportunity to explore the role of p21 in a number of p53-regulated processes. These include the role of p21 in radiosensitivity, chemosensitivity and DNA repair. Previous studies from our laboratory in human breast cancer MCF-7 and colon cancer RKO cells showed that p53 disruption sensitized these cell types to cisplatin (CDDP), an agent that induces DNA damage believed to be repaired primarily through nucleotide excision (Fan et al., 1995) . Later studies by other workers con®rmed the increased sensitivity of p53 disrupted cells to CDDP (Hawkins et al., 1996) , and similar ®ndings were reported by us for U.V.-light . Enhanced sensitivity of p53-disrupted MCF-7 and RKO cells to CDDP and U.V.-light correlated with abrogation of G 1 checkpoint control and reduced DNA repair of CDDP-and U.V.-damaged reporter plasmids transfected into the cells (Fan et al., 1995; Smith et al., 1995) . These and other studies have implicated the p53 pathway in DNA repair (Fan et al., 1995; Ford et al., 1995; Smith et al., 1995 Smith et al., , 1996 Wang et al., 1995) . The precise role that p53 and/or p53-downstream eectors play in DNA repair, however, remains relatively unexplored.
Our ®ndings that p53 can protect certain cell types from speci®c classes of DNA damaging agents contrasts with observations we have made in Burkitt's lymphoma cell lines (O'Connor et al., 1993; Fan et al., 1994) and observations from other workers using E1A-transformed mouse embryonic ®broblasts (Lowe et al., 1993) . In these situations, p53 disruption is associated with decreased sensitivity to DNA damaging agents. Such contrasting results brings into focus the importance of cellular context in dissecting the role of p53 in radiosensitivity and chemosensitivity, and indicates that in certain cases, p53 protects cells from cytotoxic chemotherapy (Fan et al., 1995; O'Connor and Fan, 1996) .
In the present study we investigated the role of p21 in chemosensitivity. We used wild-type p53 human colon cancer HCT-116 cells with either intact or disrupted p21 genes, as well as HCT-116 cells stablytransfected with the human papillomavirus type-16 E6 gene, whose product disrupts p53 function. To determine the importance of cell background to the responses gathered we also conducted studies in MEF from transgenic mice with intact versus disrupted p21 genes.
Of the agents we tested we found that HCT-116 lacking p53 and/or p21 function showed preferential sensitization to CDDP and HN2. Similar results were also obtained in MEF from transgenic mice lacking p21 genes. The enhanced sensitivity of p21 disrupted cells to CDDP correlated with reduced DNA repair activity as evidenced in host-cell reactivation assays. We also noted that p21 disrupted cells were more sensitive to S/G 2 phase cell cycle arrest than parental cells. Our results suggest that p21 is an important component of the p53 pathway that protects some cell types against DNA damage induced by cisplatin and nitrogen mustard.
Results

Characterization of HCT-116 cells with impaired p53 or p21 function
Investigations into the role of p21 in radiosensitivity and chemosensitivity were conducted in human colon carcinoma HCT-116 cells containing wild-type p53 and the same cells in which one or both copies of the p21 gene had been disrupted by homologous recombination. The development and characterization of HCT-116 lacking p21 genes has been described previously (Waldman et al., 1995) . Comparisons were made with HCT-116 cells stably transfected with control pCMV vector or the same vector encoding the human papillomavirus type-16E6 gene (HPV-E6). The E6 protein binds to p53 and stimulates p53 degradation through a ubiquitin-dependent process (Werness et al., 1990; Crook et al., 1991) , thus providing a means of disrupting p53 function in cells. The source of the HCT-116 cells used to construct the p21 disrupted cells (Johns Hopkins University, JHU) (Waldman et al., 1995) was dierent from that used to generate pCMV and pCMV-E6 transfectants (National Cancer Institute, NCI). Thus, all experiments were conducted with the original parental HCT-116 cell line from which each set of derivative lines were made. G 1 arrest in response to DNA damage has been temporally associated with a transient increase in wildtype p53 and p21 protein levels in several mammalian cell lines (El-Diery et al., 1994; Fan et al., 1994; Kastan et al., 1991; O'Connor et al., 1993) . Parental HCT-116 cells used here exhibited g-ray responses that were consistent with a wild-type p53 status. These responses included accumulation of both p53 and p21 proteins, as well as G 1 phase cell cycle arrest following girradiation (Figure 1) . The extent of G 1 arrest in parental and control transfected HCT-116 cells was less than what we had observed previously in MCF-7 cells or cells of lymphoid origin (O'Connor et al., 1993; Fan et al., 1995) . These dierences could re¯ect cell type speci®c dierences or an attenuated G 1 arrest response in HCT-116 cells. In contrast to parental cells and pCMV control-transfectants, HCT-116 clones expressing the HPV-E6 protein exhibited defective p53 function as indicated by the lack of p53 and p21 accumulation and lack of G 1 arrest following exposure to g-irradiation (Figure 1 ). HPV-E6 expression in HCT-116 cells also reduced basal expression levels of p53. Consistent with previous observations using adriamycin (Waldman et al., 1995) , we found that HCT-116 cells deleted for both copies of the p21 gene lacked the ability to G 1 arrest following irradiation with 12.6 Gy g-rays (data not shown). Despite the lack of p53 (Figure 1 ) and p21 function (data not shown), HCT-116 cells were still able to arrest in G 2 phase of the cell cycle. These results suggested that p53 and p21 are not essential components of the G 2 checkpoint.
Parental CMV-1 CMV-2 E6-1 E6-5 HCT116 a b Figure 1 Functional characterization of the G 1 and G 2 cell cycle checkpoints following g-irradiation of HCT-116 cells with intact versus disrupted p53 function. (a) Exponentially growing cells (7) were subjected to 6.3 Gy of g-rays and 4 h after the irradiation (+) cells were prepared for Western blotting. Immunodetection of p53 and p21 proteins were carried with the monoclonal antibody pAb1801 to p53 (Oncogene Science) and a polyclonal antibody to p21 (Pharmingen) as described in Materials and methods. The role of p53 and p21 function in the sensitivity of HCT-116 cells to a variety of cytotoxic agents was investigated using both MTT and clonogenic survival assays. To assess dierences in sensitivity, comparisons were made with the parental HCT-116 line from which each set of transfected derivatives were made. We found that HCT-116/E6 cells, with disrupted p53 function, were more sensitive to CDDP and HN2 than parental cells or control pCMV transfectants ( Figure 2a ). This enhanced sensitivity was seen in two independent E6 transfection clones (E6-1, E6-5), and was reminiscent of our previous ®ndings in breast cancer MCF-7 and colon cancer RKO cells (Fan et al., 1995) , and studies conducted in normal cells disrupted for p53 function (Hawkins et al., 1996) ) also showed greater sensitivity to CDDP and HN2 than the parental HCT-116 cells from which they were derived ( Figure 2b ). Enhanced sensitivity to both agents was again seen in two independent p21-disrupted clones (80S4, 80S14) and deletion of both p21 alleles was required for complete sensitization (Figure 2b ). Importantly, this enhanced sensitivity occurred despite the wild-type p53 status of HCT-116/p21
7/7 cells (Waldman et al., 1995) . Analysis of cell survival after treatment with 1.0 mM CDDP revealed that between 8 and 15% of HCT-116/p21
7/7 cells survived treatment compared with 47% cell survival for HCT-116/parental cells. Comparisons made at the ID 50 dose for CDDP revealed that p21 disrupted HCT-116 cells were on average fourfold more sensitive to CDDP than HCT-116/parental cells. At 0.5 mM of HN2, there was on average less than 3% survival for HCT-116/p21 7/7 cells compared to approximately 15% for HCT-116/parental cells. Comparisons made at the ID 50 dose for HN2 revealed that HCT-116/ p21 7/7 cells were approximately fourfold more sensitive to HN2 than HCT-116/parental cells.
We also performed MTT assays on MEF from transgenic mice lacking p21 genes (Deng et al., 1995) to determine whether such cells would also be more sensitive to CDDP and HN2. We focused our attention on the chemosensitivity of early passage cells (passage 1 and 2) to ensure for optimal growth and normal karyotype. Consistent with our observations in HCT-116 cells we found that the p21 7/7 MEF were more sensitive to CDDP (ID 50 =0.73 mM) and HN2 (ID 50 =0.5 mM) compared to MEF from normal littermates (CDDP, ID 50 =4.5 mM; HN2, ID 50 =5 mM) ( Figure 2c ). Taken together, the results described above suggest that p21 is an important downstream component of the p53 pathway that protects some cell types against the DNA crosslinking agents, CDDP and HN2.
Clonogenic survival assays were also performed on HCT-116 cells with intact versus disrupted p53 and p21 function to determine whether dierences observed in MTT survival assays would translate into dierences in clonogenicity. We treated cells with a variety of chemotherapeutic drugs or radiation and then incubated cells for 10 ± 14 days before counting colonies with greater than 50 cells per colony. This assay provides a longer-term assessment of cell growth than the MTT assay and directly assesses the ability of individual cells to proliferate into viable colonies. We tested the cytotoxicity of g-rays, adriamycin, HN2, CDDP, taxol and vincristine against HCT-116/CMV-1 and HCT-116/E6-5 cells, as well as HCT-116/parental and HCT-116/p21 7/7 (80S14) cells. The dose of agent required to reduce colony formation to 50% (ID 50 ) or 10% (ID 90 ) of the control non-treated cells is shown in Table 1 . Consistent with data gained in MTT assays, HCT-116/E6-5 cells exhibited greater sensitivity to CDDP and HN2 than control pCMV transfected HCT-116 cells. The dose-modifying factor for equivalent cell killing (ID 50 ) was 3.6 for HN2 and 4.3 for CDDP (Table 1) . Consistent with previous observations in MCF-7 and RKO cells, we failed to see alterations in g-ray or taxol sensitivity of HCT-116 cells following p53 disruption (Fan et al., 1995) . Consistent with our ®ndings in MTT assays, we found that p21 disruption sensitized HCT-116 cells to CDDP and HN2. This was evident from the approximately threefold decrease in the dose of CDDP or HN2 required to reduce colony formation by 50% compared to parental HCT-116 cells. In contrast, the clonogenic survival of HCT-116 cells treated with a variety of other cytotoxic agents was relatively unaected by p21 disruption (Table 1) . Our results suggested that p21 disruption preferentially sensitizes HCT-116 cells to DNA crosslinking agents. p53 or p21 disruption reduces host cell reactivation of CDDP-damaged CAT-reporter plasmids
In our previous studies we hypothesized that the enhanced CDDP-sensitivity of p53 disrupted MCF-7 and RKO cells was due to reduced nucleotide excision repair activity (Fan et al., 1995) . In the present study we investigated whether reduced DNA repair activity was evident in HCT-116 cells disrupted for p53 or p21 function. We transfected CDDP-damaged CAT-reporter plasmids into HCT-116 cells with intact versus disrupted p53 or p21 function, and then measured the ability of cells to reactivate these damaged plasmids.
Comparisons were made with a control undamaged plasmid and appropriate corrections were made for transfection eciency. Host cells having greater DNA repair activity should reactivate the damaged plasmid to a greater extent than cells having reduced or defective DNA repair activity (Dabholkar et al., 1990; Protic et al., 1988) . The XP12BE cell line, derived from a xeroderma pigmentosum group A patient which is defective in nucleotide excision repair (Robbins, 1974) was employed to con®rm that the level of CDDP damage introduced into the plasmid was sucient to completely inactivate the CAT gene in the plasmid (Figure 3) . Thus, any CAT activity observed in HCT-116 cells must be due to DNA repair. We found that HCT-116/parental and pCMV transfected HCT-116 cells (HCT-116/CMV-1) were able to recover CAT activity from the CDDP-damaged plasmid to approximately 80 ± 90% of that achievable with the undamaged plasmid. When the same CDDP-damaged CAT plasmid was transfected into HCT-116/E6-5, however, only about 40% of control CAT activity was recovered by the end of the assay. These results indicated that HCT-116/E6 cells were approximately twofold less competent at reactivating the CDDP-damaged CAT plasmid compared to the control cells. These results are in agreement with our previous ®ndings in MCF-7 cells (Fan et al., 1995) . We also found that HCT-116/p21
cells were approximately twofold less competent at reactivating the CDDP-damaged CAT plasmids compared to parental HCT-116 cells (Figure 3) . These results supported the hypothesis that the enhanced CDDP-sensitivity of p53 and p21 disrupted HCT-116 cells is related to reduced DNA repair activity (Fan et al., 1995) . cells with increasing concentrations of HN2 and measured cell cycle progression by¯ow cytometry. HN2 was chosen over CDDP for these studies since DNA crosslinks induced by HN2 form more rapidly than CDDP (O'Connor et al., 1991; Zhen et al., 1992) . Cells were continuously incubated with bromodeoxyuridine (BrdU) so that we could measure progression of cells through S phase and into the second cell cycle. cells with relatively low doses of HN2 (0.1 ± 0.25 mM) resulted in a marked accumulation of cells in the ®rst G 2 phase. In contrast, these same doses of HN2 had minimal eect on cell cycle progression of parental HCT-116 cells (compare rows 3 and 4 of Figure 4 ). As the dose of HN2 was increased from 0.25 mM to 1 mM, the p21 7/7 cells became progressively arrested in the ®rst S phase while at these doses, parental HCT-116 cell displayed primarily a G 2 arrest (see row 6 of Figure  4 ). We estimated that two to threefold higher doses of HN2 were required to arrest a similar fraction of parental HCT-116 cells in G 2 phase compared to HCT-116/p21 7/7 cells. This degree of dierence was similar to that required for an equivalent level of HN2-induced cytotoxicity in parental and p21
HCT-116 cells (see Figure 2 and Table 1 ). These results demonstrated that HCT-116/p21
7/7 cells were cells (clone 80S14). Studies were also conducted on XP12BE cells which have defective nucleotide excision repair activity (Robbins, 1974) . Seventy-two hours after transfection, the cells were lysed, and CAT activity was measured on a Phosphor-Imager Analyzer. 
Discussion
We have previously shown that p53 disruption in breast carcinoma MCF-7 or colon carcinoma RKO cells enhances CDDP-induced cytotoxicity (Fan et al., 1995) . In the present study we extended these observations to colon cancer HCT-116 cells and report that HCT-116 cells, as well as, MEF lacking p21 genes also exhibit enhanced CDDP-sensitivity. Enhanced sensitivity was not limited to CDDP since another DNA crosslinking agent, HN2, was also more cytotoxic to p53 and p21 defective cells. Enhanced CDDP-sensitivity correlated with reduced DNA repair activity, as evidenced in host cell reactivation assays, and such cells were also more sensitive to DNA damage-induced cell cycle delay than their parental counterparts. These results are consistent with an important role for p21 in protecting cells against DNA crosslinking agents. CDDP-induced DNA damage is believed to be repaired primarily through nucleotide excision (Zhen et al., 1992 and references therein), and a role for p53 and/or p53-eectors in nucleotide excision repair has been suggested by a number of workers investigating the p53-regulated Gadd45 protein (Smith et al., 1994 (Smith et al., , 1996 , p53's interaction with ERCC3 and TFIIH (Wang et al., 1995) , as well as, isogenic cell line systems with intact versus disrupted p53 function (Fan et al., 1995, Ford and Hanawalt, 1995) . In agreement with these studies, we show in present manuscript, that p53-disruption in HCT-116 cells preferentially sensitizes these cells to DNA crosslinking agents such as CDDP and HN2, and that this sensitization correlates with reduced DNA repair activity as assayed using host cell reactivation assays. We also present data that supports a role for p21 in repair of cisplatin-induced DNA damage and show that p21 function is required to protect at least some cell types against DNA crosslinking agents. This protection could be seen in two dierent cell backgrounds: HCT-116 and MEF from p21 knock-out mice, demonstrating that the genetic composition of HCT-116 cells, which are known to be mismatch repair defective (Waldman et al., 1995) , is not a unique environment in which sensitization is generated by p21 disruption. Our ®ndings that p21 contributes to host cell reactivation activity is supported by two other recent studies. In the ®rst, MacDonald et al. (1996) showed that HCT-116/p21 7/7 cells were less capable of repairing DNA damaged reporter plasmids than parental HCT-116 cells. In the second study, Sheikh et al. (1997) showed using a tetracycline-regulated promoter to control p21 expression in a mutant-p53 line that p21 overexpression enhanced the repair of ultraviolet-light-damaged reporter plasmids transfected into the cells. Taken together these studies indicate a role for p21 in DNA repair. Although, we were unable to conduct host cell reactivation assays in MEF, due to poor transfection eciency, we predict that MEF/p21 7/7 will also be found to exhibit reduced DNA repair activity since such cells were also more sensitive to CDDP and HN2 than MEF from normal littermates (Figure 2c ).
One possible route by which p21 could contribute to DNA repair process is through its interaction with PCNA (Li et al., 1994; Shivji et al., 1994; Waga et al., 1994) , a protein involved in DNA replication and DNA repair. However, some studies have failed to see a positive eect of p21, at least in in vitro nucleotide excision repair assays (Li et al., 1994; Shivji et al., 1994; Waga et al., 1994) , and one study has even reported that p21 inhibits nucleotide excision repair (Pan et al., 1995) . One might explain the apparent discrepancy between these in vitro observations and the suggestions made from our cellular studies if p21's eects on nucleotide excision repair were: (1) concentrationdependent; or (2) dependent on the presence of other cellular components absent from the in vitro repair extracts. Assessment of the nucleotide excision repair activity of extracts prepared from cells with intact versus disrupted p21 genes might prove enlightening in this regard. Another possibility worth considering is that p21 might mediate its eects through a DNA repair process other than nucleotide excision repair. A focal point for future studies will be the interaction of p21 with PCNA whose involvement in nucleotide excision repair has recently been expanded to also include mismatch repair (Umar et al., 1996) and post replication repair (Torres-Ramos et al., 1996) . Interestingly, another PCNA binding protein, Gadd45 also appears to contribute to DNA repair. This was ®rst demonstrated using in vitro DNA repair assays (Smith et al., 1994) and more recently using host cell reactivation assays in cells stably expressing antisense GADD45 (Smith et al., 1996) . Indeed, p21 and Gadd45 interact with PCNA in a competitive fashion, suggesting that both proteins may regulate PCNA function in dierent ways .
Our studies also revealed that HCT-116/p21 7/7 cells were much more susceptible to HN2-induced cell cycle delay than parental cells. This delay was manifested at low HN2 concentrations as G 2 arrest, and at higher HN2 concentrations primarily as S phase arrest. The dose-dependency of the HN2-induced cell cycle eects suggested that for a given HN2 dose, the p21 7/7 cells either accumulated a higher level of DNA lesions or that HCT-116/p21 7/7 were less able to repair an equivalent load of HN2-induced DNA lesions compared to parental cells (O'Connor et al., 1991) . Data gathered using host cell reactivation assays supports the latter explanation that HCT-116/p21 7/7 cells are less able to repair DNA damage compared to parental cells. This lack of DNA repair is detected by the S and G 2 checkpoints which attempt to hold the cells stationary until this repair is completed. Once the dose of HN2 exceeded 1 mM, however, the cell cycle responses of parental and p21-disrupted HCT-116 cells became almost indistinguishable. Such results might be explainable on the basis of a saturable DNA repair process involving p21. In this case p21 would aid the repair of low levels of DNA damage. Importantly, 7/7 cells, despite losing G 1 checkpoint function, were still capable of arresting in G 2 and S phase following DNA damage. These results suggested that the S and G 2 checkpoints are operationally in p21 7/7 cells. We have recently investigated whether the S and G 2 arrest responses were indeed controlled by checkpoints by exposing cells to pentoxifylline or UCN-01 (Fan et al., 1995; Wang et al., 1996) . We found that such agents abrogated HN2-induced cell cycle arrest in HCT-116/p21
7/7 cells (HN2=2 mM, J Chang and PM O'Connor, unpublished observations).
p21 and chemosensitivity S Fan et al Waldman et al. (1996) recently showed that HCT-116/p21 7/7 cells tended towards polyploidization following treatment with DNA damaging agents. However, a signi®cant period of time (up to 60 h) was necessary to observe polyploid cells. Our cell cycle responses to HN2 focused on measurements up to 20 h following drug exposure and thus were too early to observe the development of polyploid cells.
In contrast to the enhanced sensitivity of HCT-116/ E6 and HCT-116/p21
7/7 cells to CDDP and HN2, we failed to see any marked dierences in the sensitivity of these cells to a number of other cytotoxic agents, including g-rays. Our cytotoxicity comparisons were made in clonogenic survival assays and sensitivity in this assay is dependent on the ability of single cells to proliferate into viable colonies of greater than 50 cells to be scored as a colony (approximately 6 cell doublings). Thus, the enhanced sensitivity of 7/7 cells to apoptosis does not appear, in all cases, to translate into dierences in long-term survival, at least as measured by clonogenic survival assays. Our results with HCT-116/E6 are consistent with clonogenic survival assay results conducted earlier in MCF-7 and RKO cells (Fan et al., 1995) . In these earlier studies we failed to observe dierences in radiosensitivity following p53 disruption.
In summary, we found that HCT-116 lacking p53 or p21 function exhibited preferential sensitization to CDDP and HN2. Similar ®ndings were obtained in MEF from mice lacking p21 genes. The enhanced CDDP-sensitivity of p53 and p21 disrupted HCT-116 cells correlated with reduced DNA repair activity as evidenced in host-cell reactivation assays, and the p21 disrupted cells were also much more sensitive to cell cycle arrest induced by HN2 than parental HCT-116 cells. Our results indicate that p53 and p21 function can protect, at least some cell types against DNA crosslinking agents. Further investigations into this and other pharmacologic vulnerabilities in cells with defective p53 function might provide a path to the discovery of new chemotherapeutic stratagems for cancer treatment (O'Connor, 1996) .
Materials and methods
Cell culture and stable transfection
Colon carcinoma HCT-116 cells (graciously provided by the Developmental Therapeutic Program, NCI) and xeroderma pigmentosum XP12BE cells (graciously provided by Dr Jay Robbins) were cultured in RPMI-1640 medium (Gibco-BRL) containing 5% fetal bovine serum (Sigma) and 2 mM L-glutamine. For stable transfection, 1610 6 HCT-116 cells were seeded in 10 cm 2 diameter petri dishes 24 h before transfection. HCT-116 cells were transfected with control pCMV vector (graciously provided by Dr Bert Vogelstein) or the same vector containing the human papillomavirus type-16 E6 gene (graciously provided by Dr Kathleen Cho) by use of lipofectamine reagent (Gibco-BRL). The pCMV plasmids also contained a neomycin gene which allowed neomycin resistant colonies to be selected 14 days after transfection. Following expansion, colonies demonstrating lack of g-ray-induced G 1 arrest and lack of g-ray-induced p53 and p21 protein accumulation were selected for chemosensitivity analysis. The generation and characterization of p21-de®cient HCT-116 cells and MEF have been described previously (Deng et al., 1995; Waldman et al., 1995) . MEF were maintained in minimal essential medium containing 10% fetal calf serum as described previously (Deng et al., 1995) .
Irradiation and drug treatment
Irradiation was performed using a 137 Cs source delivering g-rays at a dose rate of 3.46 Gy/min. adriamycin, CDDP, HN2, vincristine and taxol were obtained from the Drug Synthesis and Chemistry Branch, Developmental Therapeutics Program, National Cancer Institute. Stock solutions of vincristine and taxol were prepared in DMSO. adriamycin was prepared in deionized water and stored at 7208C until use. CDDP was dissolved in phosphate buered saline (PBS) and HN2 was dissolved in 0.1 M HCl. Except in the case of taxol and vincristine, where treatment was for 24 h, cells were treated with chemical agents for 1 h at 378C.
Survival assays
Cytotoxicity was evaluated using clonogenic or MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) survival assays. For clonogenic survival, cells were plated in replicate 10 cm 2 diameter petri dishes for 24 h, rinsed with fresh medium and then irradiated or treated with various chemical agents. Cells were then washed twice with fresh medium, incubated for 10 ± 14 days and the number of colonies formed (450 cells) counted after staining with Giemsa (Sigma). The plating eciency of the untreated cells was between 60 and 80%. For the MTT assay, 250 and 500 HCT-116 cells or 3000 MEF in 200 ml of complete medium were placed into each well of a 96-well plate. Five replicate wells were used to assess the toxicity of each concentration of drug. Twenty-four h later drugs were added and left in the culture for 5 days for HCT-116 cells and 3 days for MEF. At these times, viability was assessed by the ability of cells to convert the soluble salt of MTT into an insoluble formazan precipitate which was quantitated spectrophotometrically following solubilization in DMSO, as described previously (Fan et al., 1995 and references therein) .
Flow cytometry
Propidium iodide (PI) staining of cells was performed essentially as described previously (O'Connor et al., 1993) . Brie¯y, cells were ®xed in ice-cold 70% ethanol, washed with PBS, treated with RNase (Sigma, 500 units/ml) at 378C for 15 min, and stained with PI (Sigma, 50 mg/ml). To assay bromodeoxyridine (BrdU) incorporation, cells were pre-incubated with 10 mM BrdU (Sigma) for 4 h before treatment with HN2 for 1 h. Cells were then postincubated for 20 h in medium that contained BrdU (10 mM), washed with PBS and then ®xed in 70% ethanol for 24 h at 48C. Cells were subsequently resuspended in 1 ml of 0.1 M HCl containing 0.25% (v/v) Triton X-100 and left on ice for 10 min. After this, cells were diluted with 5 ml of distilled deionized water, centrifuged and then resuspended in 2 ml of distilled deionized water. Samples were boiled for 10 min, cooled on ice for 10 min, washed in 5 ml of PBS containing 0.25% (v/v) Triton X-100 (PBS-T) and then resuspended in 0.1 ml of PBS-T containing 10 mg/ ml of an anti-BrdU-¯uorescein conjugated antibody (Becton-Dickinson). Cells were then left on ice for 30 min before incubation with PI (25 mg/ml) and RNase (10 mg/ml, Pharmacia Biotech) for 30 min at 378C. Cell cycle analysis was performed using a Becton-Dickinson FACSCAN¯ow p21 and chemosensitivity S Fan et al cytometer. The Cell-Quest software package (BectonDickinson) was used to analyse data on 15 000 cells in each individual sample.
Gel electrophoresis and Western blot analysis
Samples were lysed on ice for 30 min in 1% Nonidet P-40 prepared in PBS that contained 10 mg/ml leupeptin, 10 mg/ml aprotinin, 2 mM 4-(2-aminoethyl)benzene sulfonyl¯uoride, 1 mM sodium o-vanadate, 10 mM sodium uoride, and 5 mM sodium pyrophosphate. Soluble protein was then boiled for 5 min in a SDS-loading buer and 100 mg of total cell protein loaded onto either 10% (p53) or 15% (p21) SDS-polyacrylamide gels. Proteins were then electrophoretically transferred to Immobilon membranes (Millipore) and blocked for 30 min in 5% non-fat milk at room temperature. Immunodetection of p53 protein was performed with the monoclonal pAb1801 antibody (Oncogene Science), and for p21 determination a polyclonal antibody (PharMingen) was used. Antibody reaction was revealed using enhanced chemiluminescence according to the manufacturer's recommendations (Amersham).
Host cell (CAT) reactivation assay
The non-replicating pSV 2 CAT plasmid, encoding bacterial chloramphenicol acetyltransferase (CAT), was treated with 10 mM CDDP in 1 mM Tris-HCl, pH 7.8, 10 mM NaCl and 1 mM EDTA for 1 h at 378C. The HCT-116 cell lines were then transfected with 5 mg of the CDDP-damaged or undamaged pSV 2 CAT plasmid using lipofectace reagent (Gibco-BRL). To normalize for transfection eciency, 0.5 mg of pSV 2 AP plasmid, which encodes the alkaline phosphatase protein, was included in the transfections. Transient CAT gene expression was assayed 72 h after transfections. Quantitation of 14 C-chloramphenicol conversion was performed by counting on a Phosphor-Imager analyzer (Molecular Dynamics). Values were normalized to the alkaline phosphatase internal control, and values expressed relative to the CAT activity obtained for the undamaged CAT plasmid in each cell line (Dabholkar et al., 1990; Protic et al., 1988) .
Abbreviations ADR, adriamycin; CDDP, cisplatin; HN2, Nitrogen Mustard; VCR, Vincristine; CMV, cytomegalovirus; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide; PBS, phosphate buered saline; U.V., ultraviolet light; CAT, chloramphenicol acetyltransferase; MEF, murine embryonic ®broblasts.
